Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111013038

Candesartan Cilexetil Related Compound G Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111013038
Click to view available options
Quantity:
20 mg

Description

Candesartan Cilexetil Related Compound G is an impurity of candesartan cilexetil (CAN), which is classified as an angiotensin II receptor antagonist. CAN finds application in the treatment of hypertension, and can be used in cardiac patients with impaired left ventricular systolic function. It is a pharmaceutical secondary standard for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
TRUSTED_SUSTAINABILITY

Specifications

CAS 139481-59-7
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C24H20N6O3
Synonym Candesartan; 1-{[2′-(1 H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid(Candesartan Cilexetil Related Compound G); 2-Ethoxy 1-{[2′-(1 H-tetrazol-5-yl)biphenyl-4-yl]methyl}benzimidazole-7-carboxylic acid
Type Certified Reference Material
Quantity 20 mg
Formula Weight 440.45
Grade Certified Reference Material
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.